Cargando…

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Detalles Bibliográficos
Autores principales:	Heudel, P., Favier, B., Assaad, S., Zrounba, P., Blay, J.-Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321960/ https://www.ncbi.nlm.nih.gov/pubmed/34333128 http://dx.doi.org/10.1016/j.annonc.2021.07.012

Ejemplares similares

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
por: Heudel, Pierre, et al.
Publicado: (2022)

Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
por: Assaad, Souad, et al.
Publicado: (2021)

1503. Risk Factors for Contracting Infection with SARS-CoV-2: a Prospective Case-control Study
por: Shoar, Saeed, et al.
Publicado: (2020)

1503. Impact of Sars-Cov-2 (Covid-19) in Patients Living with HIV from United States National Inpatient Sample Database
por: Patel, Premalkumar M, et al.
Publicado: (2023)

1503 Individual Accountability and Direct Feedback to Achieve and Sustain Good Hand Hygiene Performance
por: Maragakis, Lisa L., et al.
Publicado: (2014)

Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases
por: Chu, Cindy S, et al.
Publicado: (2023)

Deaths associated with newly launched SARS-CoV-2 vaccination
por: Mungmunpuntipamtip, Rujittika, et al.
Publicado: (2021)

1503. No Benefit to Treating Male UTI for Longer Than 7 Days: An Outpatient Database Study
por: Germanos, George, et al.
Publicado: (2018)

P1503: ETIOPATHOGENESIS OF CANCER-RELATED ANEMIA AMONG CHILDREN AND ADOLESCENTS WITH MALIGNANT SOLID TUMORS
por: Kader, Salwa Mostafa Abd El Kader, et al.
Publicado: (2023)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Bilateral retinal vein occlusion after two doses of SARS-CoV-2 adenovirus vector-based vaccine
por: Fernández-Vigo, J.I., et al.
Publicado: (2022)

Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2
por: Souto Ferreira, Leonardo, et al.
Publicado: (2022)

Medición de la resistencia de aislamiento a máquinas eléctricas utilizando megger modelo 1503 /
por: Marín Solís, José Heriberto
Publicado: (2011)

Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
por: Solodky, M.L., et al.
Publicado: (2020)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV
por: Moussaoui, Majdouline El, et al.
Publicado: (2022)

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
por: Li, Xue, et al.
Publicado: (2023)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
por: Iwasa, Satoru, et al.
Publicado: (2020)

Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
por: Palich, R., et al.
Publicado: (2021)

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022)

1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium Difficile Infection (CDI)
por: Ford, Christopher, et al.
Publicado: (2019)

OA15.03. Cost savings associated with mindfulness meditation and moderate exercise intervention in the common cold (The MEPARI Study)
por: Rakel, D, et al.
Publicado: (2012)

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
por: Siva, Shankar, et al.
Publicado: (2018)

SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine
por: Giménez, Estela, et al.
Publicado: (2022)

Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
por: Atanasio, A., et al.
Publicado: (2023)

Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: McEvoy, Caitríona M., et al.
Publicado: (2022)

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
por: Ai, Jingwen, et al.
Publicado: (2021)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
por: Finsterer, Josef
Publicado: (2023)

Consider Alternative Causes of Death to SARS-CoV-2 Vaccination-Related Guillain–Barre Syndrome without Dysautonomia
por: Finsterer, Josef
Publicado: (2022)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

Subacute thyroiditis after SARS-CoV-2 vaccination: report of two clinical cases()
por: González López, Javier, et al.
Publicado: (2022)

Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b6p4ccq4gu131rh6k5h8kkkl8c